Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 102

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 102
---
 and align executives’ interests with those of our stockholders.

As required by Item 402(v) of Regulation S-K, we are providing the following information about the relationships between compensation actually paid to our NEOs and company performance. In this section, we refer to compensation actually paid (“CAP”) and other terms used in the applicable SEC rules. For information concerning our compensation philosophy, refer to “Compensation Discussion and Analysis” above.

Pay Versus Performance Table (1)

|      |     |                     |     |             |     |                                        |     |               |     |                                            |     |            |     |                                        |     |            |     |                                                            |     |             |     |                                                       |     |              |     | Value of Initial Fixed $100 Investment(2) |     |      |     |                                        |     |      |     |                          |     |          |     |                                                    |     |        |
| Year |     | Summary             
 Compensation        
 Table (“SCT”) Total 
 for PEO 1           |     |             |     | Compensation Actually Paid to PEO 1(3) |     |               |     | Summary Compensation Table Total for PEO 2 |     |            |     | Compensation Actually Paid to PEO 2(3) |     |            |     | Average  Summary Compensation Table Total for Non-PEO NEOs |     |             |     | Average Compensation Actually Paid to Non-PEO NEOs(3) |     |              |     | Total Shareholder Return                  |     |      |     | Peer Group Total Shareholder Return(4) |     |      |     | Net Income (in millions) |     |          |     | Company Selected Measure: Revenue (in millions)(5) |     |        |
| 2024 |     |                     |     |  $9,181,620 |     |                                        |     |  $(5,981,089) |     |                                            |     |        N/A |     |                                        |     |        N/A |     |                                                            |     |  $3,602,541 |     |                                                       |     | $(4,385,477) |     |                                           |     |  $36 |     |                                        |     | $118 |     |                          |     | $(309.9) |     |                                                    |     | $154.0 |
| 2023 |     |                     |     |  $8,046,575 |     |